Vaccinogen Revenue
Biotechnology Research • 
Baltimore, Maryland, United States • 1-10 Employees
Vaccinogen revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Key Contacts at Vaccinogen
Oksana S. Levin
Board Of Directors - Director
Michael Hanna
Director, Chairman Emeritus
Michael G Hanna
Founder, Director, Chairman Emeritus
Michael Hanna
Founder And Ceo
Michael Hanna
Chief Executive Officer
Company overview
| Headquarters | Baltimore, Maryland, United States |
| Phone number | +13016688400 |
| Websites | |
| NAICS | 541714 |
| Keywords | Cancer Research And Immunotherapy |
| Founded | 2007 |
| Employees | 1-10 |
| Socials |
Vaccinogen Email Formats
Vaccinogen uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@vaccinogentx.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@vaccinogentx.com | 66.7% |
{first name} | john@vaccinogentx.com | 33.3% |
About Vaccinogen
Vaccinogen is a US-based biotechnology company formed in 2007 currently commercializing a personalized immunotherapy designed to prevent disease recurrence after cancer surgery (OncoVAX®). Using a patient’s own tumor as the source material for their treatment, this patented approach has proven to prevent advanced stage II colorectal cancer recurrence with 15 years of patient follow-up compared to surveillance alone. While this Phase IIIb study with Fast Track Designation represents the most near-term source of revenue for the company, new sources of funding will also allow Vaccinogen to develop and commercialize the truly unique, cancer-specific antibodies created by OncoVAX patients into the next product portfolio for the company: bispecific T-cell engagers, antibody-drug conjugates, solid tumor CAR-T, and radioligands with broad specificity against a range of adenocarcinomas – each with pipeline in a product potential. See our website for more details on our science and contact information for investment opportunities.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Vaccinogen has 5 employees across 3 departments.
Departments
Number of employees
Funding Data
Vaccinogen has never raised funding before.
Vaccinogen Tech Stack
Discover the technologies and tools that power Vaccinogen's digital infrastructure, from frameworks to analytics platforms.
Tag managers
Hosting
CMS
Miscellaneous
Security
JavaScript frameworks
JavaScript frameworks
Miscellaneous
Analytics
Live chat
Netherlands
Germany
Canada
Bolivia, Plurinational State of
United Kingdom
FranceFrequently asked questions
4.8
40,000 users
